{"gao_id": "GAO-20-572", "published": "2020-07-29T12:00:00Z", "released": "2020-07-29T08:00:00Z", "summary": "For years, most over-the-counter drugs followed requirements called \"monographs\" for each category of drugs (e.g., sunscreen or cough and cold medicine). To update a monograph, FDA followed the federal rulemaking process, which could take years. FDA said this process and insufficient resources limited its ability to quickly respond to safety issues. In March 2020, the CARES Act gave FDA new tools to regulate these over-the-counter...", "title": "Over-The-Counter Drugs: Information on FDA's Regulation of Most OTC Drugs", "topics": ["Drug safety", "Medicine", "Over-the-counter drugs", "Drug approvals", "Safety", "Federal rulemaking", "Skin cancer", "Health Care", "Prescription drugs", "Drugs", "Safety regulation"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-20-572", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-20-572-highlights.pdf"}, {"title": "Full Report (27 pages)", "url": "https://www.gao.gov/assets/gao-20-572.pdf"}, {"title": "Accessible PDF (31 pages)", "url": "https://www.gao.gov/assets/710/708535.pdf"}]}